Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Hematology
Reference43 articles.
1. Löwenberg B, Downing JR, Burnet A: Acute myeloid leukemia. N Engl J Med 1999, 341: 1051–1062. 10.1056/NEJM199909303411407
2. Momparler RL: A model for the chemotherapy of acute leukemia with 1-ß- arabinofuranosylcytosine. Cancer Res 1974, 34: 1775–1787.
3. Reese ND, Schiller GJ: High-dose cytarabine (HD araC) in the treatment of leukemias: a review. Curr Hematol Malig Rep 2013, 8: 141–148. 10.1007/s11899-013-0156-3
4. Rudnick SA, Cadman EC, Capizzi RL, et al.: High dose cytosine arabinoside (HDARAC) in refractory acute leukemia. Cancer 1979, 44: 1189–1193. 10.1002/1097-0142(197910)44:4<1189::AID-CNCR2820440404>3.0.CO;2-O
5. Early AP, Preisler HD, Slocum H, et al.: A pilot study of high-dose 1-beta-D- arabinofuranosylcytosine for acute leukemia and refractory lymphoma: clinical response and pharmacology. Cancer Res 1982, 42: 1587–1594.
Cited by
44 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献